Nigeria’s HIV Treatment Crisis Deepens in the East After US Aid Freeze: What It Means for Patients and Healthcare Systems
The sudden freeze on a portion of United States foreign aid has triggered a severe shortage of antiretroviral (ARV) medications in eastern Nigeria, threatening the lives of hundreds of thousands of people living with HIV. This disruption, which began in early 2025, has hit Benue State particularly hard—a region already grappling with one of the highest HIV prevalence rates in the country. Without immediate intervention, the gains made over two decades in controlling the epidemic could be reversed.
Why the US Aid Freeze Matters for HIV Treatment in Nigeria
The United States has long been the largest bilateral donor to global HIV programs through initiatives like the President’s Emergency Plan for AIDS Relief (PEPFAR). In Nigeria, PEPFAR has supported over 1.5 million people with life-saving antiretroviral therapy. The recent freeze—linked to broader geopolitical shifts and budget reallocations—has abruptly cut off funding for drug procurement, laboratory testing, and community health worker salaries in several states, including Benue, Taraba, and parts of Adamawa.
For patients, this means interrupted access to ARVs, which can lead to viral rebound, drug resistance, and increased transmission rates. A patient who misses even a few doses may see their viral load spike, making them more infectious and reducing future treatment options. The World Health Organization warns that treatment interruptions of more than 48 hours can compromise long-term outcomes.
Benue State: A Microcosm of a National Emergency
Benue State, located in the North-Central region, has an HIV prevalence of approximately 5.6%—nearly double the national average. The state relies heavily on U.S.-funded clinics and mobile outreach teams to deliver ARVs to remote communities. With the freeze, many of these clinics have reduced hours or closed entirely. Volunteers—often former patients or local health workers—are now stepping in to distribute remaining stock, but supplies are dwindling fast.
For example, in the town of Otukpo, a volunteer-run network has been rationing medications, giving patients only a two-week supply instead of the standard three months. This forces patients to travel more frequently, incurring transport costs that many cannot afford. Some have resorted to sharing pills with family members, a dangerous practice that can lead to underdosing and resistance.
Practical Example: The Story of Amina
Amina, a 34-year-old mother of three in Makurdi, the state capital, has been on ARVs for seven years. She recently learned that her usual clinic can no longer provide her medication. “I have enough for two more weeks,” she says. “After that, I don’t know what I will do.” Her story is not unique. Across Benue, thousands of patients face similar uncertainty, and the psychological toll is immense—fear of illness, stigma, and the loss of hard-won health stability.
Broader Implications for Nigeria’s HIV Response
The crisis in the east is a stark reminder of the fragility of donor-dependent health systems. Nigeria’s domestic HIV budget covers only about 30% of the need, leaving the country vulnerable to shifts in foreign policy. The freeze also affects prevention programs, including pre-exposure prophylaxis (PrEP) for at-risk populations and prevention of mother-to-child transmission (PMTCT). Without these services, new infections could rise sharply.
Moreover, the disruption undermines trust in the healthcare system. Patients who experience treatment interruptions may be reluctant to re-engage with services, fearing future instability. This could lead to a surge in advanced HIV disease, hospitalizations, and deaths—outcomes that were largely preventable.
What Can Be Done? Short-Term and Long-Term Solutions
In the immediate term, the Nigerian government and international partners must work to bridge the funding gap. Emergency procurement of ARVs through the Global Fund or other mechanisms could prevent a full-blown catastrophe. Local pharmaceutical manufacturers, such as those in Lagos, could be contracted to produce generic ARVs at lower cost, reducing dependence on imports.
Longer-term, Nigeria must accelerate its domestic financing commitments under the Abuja Declaration, which calls for 15% of national budgets to be allocated to health. Currently, the country spends less than 5%. Strengthening local supply chains, investing in community health worker programs, and diversifying donor partnerships are essential steps toward resilience.
Key Takeaways for Readers
- HIV treatment interruptions are dangerous: Missing doses can lead to drug resistance and increased transmission.
- Volunteers are the frontline: In Benue, community networks are keeping patients alive, but they cannot sustain this alone.
- Policy change is urgent: The U.S. aid freeze highlights the need for Nigeria to build a self-sufficient HIV response.
- Global solidarity matters: International donors must honor commitments to avoid reversing decades of progress.
The situation in eastern Nigeria is a warning sign for the entire global health community. As the world’s second-largest HIV epidemic, Nigeria’s stability is critical to achieving the UNAIDS 95-95-95 targets by 2030. Without swift action, the freeze on U.S. aid could become a turning point—not just for Nigeria, but for the fight against AIDS worldwide.
Source: Adapted from France 24 report by Awa Diouf. For further reading, visit the original article.